Levy-Cooperman, N., Kelsh,
Patients have a right to be told that they are at the end of their lives. Informing the patient that they will die is important as it will help them make decisions on end of life care. However, it is also necessary to choose words proper when disclosing this information. Also, Lee & Sörensen, (2019), recommends that the disclosure about death and making decisions on end of life care should be done in the presence of family members.
8
A patient has a right to be given information about treatment, I would tell the patients about the medication. Hydromorphone is an opioid given to patients with severe pain when other medications have failed (Walsh et al., 2017). I would also include the fact that as an opioid, the drug is highly addictive and discourage the patient against using it unless when extremely necessary.
References
Lee, J. E., & Sörensen, S. (2019). FUTURE CARE PLANNING AND END-OF-LIFE CARE DECISION MAKING: INDIVIDUAL AND SOCIAL INFLUENCES. Innovation in Aging, 3(Supplement_1), S425-S425.
Levine, D. R., Johnson, L. M., & Baker, J. N. (2017). Navigating nondisclosure requests in pediatrics: Honesty and sensitivity are transcultural practices. JAMA pediatrics, 171(11), 1044-1045.
Tappen, R. M., Weiss, S. A., Whitehead, D. K., & Fletcher, M. (2004). Essentials of nursing leadership and management.
Walsh, S. L., Comer, S. D., Lofwall, M. R., Vince, B., Levy-Cooperman, N., Kelsh, D., … & Sheldon, B. (2017). Effect of buprenorphine weekly depot (CAM2038) and hydromorphone blockade in individuals with opioid use disorder: a randomized clinical trial. JAMA psychiatry, 74(9), 894-902.
